Skip to main content
Erschienen in: Head and Neck Pathology 4/2023

16.10.2023 | Research

Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study

verfasst von: Deepak Pandiar, E. Aswani, Reshma Poothakulath Krishnan

Erschienen in: Head and Neck Pathology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Oral submucous fibrosis (OSMF) is a habit related potentially malignant disorder seen mainly in South Asian people. The malignancy arising from OSMF has been regarded as low grade with better outcome. The present study was orchestrated to histochemically analyze collagen and elastic fibres in OSMF without dysplasia, OSMF with dysplasia and OSMF turning malignant.

Materials and Methods

100 cases (80 cases and 20 healthy controls) were included after obtaining clearance from ethical committee. All cases were subjected to Van Gieson staining for collagen and a novel simple method for elastic fibres (Orcein staining). Data were analyzed using SPSS software.

Results

Controls showed haphazard arrangement of collagen and elastic fibres. The collagen bundles were parallelly arranged in OSMF without dysplasia and OSMF with dysplasia; the collagen was however haphazard in cases of OSMF turning malignant. As with collagen, elastic fibres were also haphazardly arranged in the control group; in contrast, the elastic fibres were predominantly arranged in a criss-cross pattern in the other study groups. The difference in orientation and density among the groups was statistically significant.

Conclusion

With advancement of stage there is increased collagenization of OSMF, as the condition acquires dysplastic changes and turns malignant, microenvironment alters resulting in increased activity of collagenases. However, the arrangement of more resistant elastic fibres depicts the better outcome, once OSMF shows malignant transformation, limiting locoregional and distant spread.
Literatur
1.
Zurück zum Zitat Parola M, Pinzani M (2019) Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37–55CrossRefPubMed Parola M, Pinzani M (2019) Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37–55CrossRefPubMed
3.
Zurück zum Zitat Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22(6):764–779CrossRefPubMed Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22(6):764–779CrossRefPubMed
4.
Zurück zum Zitat Sirsat SM, Pindborg JJ (1967) The vascular response in early and advanced oral submucous fibrosis. Acta Pathol Microbiol Scand 70(2):179–184CrossRefPubMed Sirsat SM, Pindborg JJ (1967) The vascular response in early and advanced oral submucous fibrosis. Acta Pathol Microbiol Scand 70(2):179–184CrossRefPubMed
5.
Zurück zum Zitat Sirsat SM, Pindborg JJ (1967) Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70(2):161–173CrossRefPubMed Sirsat SM, Pindborg JJ (1967) Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70(2):161–173CrossRefPubMed
6.
Zurück zum Zitat Pandiar D, Krishnan RP, Ramani P, Anand R, Sarode S (2023) Oral submucous fibrosis and the malignancy arising from it, could best exemplify the concepts of cuproplasia and cuproptosis. J Stomatol Oral Maxillofac Surg 124(1S):101368CrossRefPubMed Pandiar D, Krishnan RP, Ramani P, Anand R, Sarode S (2023) Oral submucous fibrosis and the malignancy arising from it, could best exemplify the concepts of cuproplasia and cuproptosis. J Stomatol Oral Maxillofac Surg 124(1S):101368CrossRefPubMed
7.
Zurück zum Zitat Pandiar D, Shameena P (2014) Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis. J Oral Maxillofac Pathol 18(2):155–161CrossRefPubMedPubMedCentral Pandiar D, Shameena P (2014) Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis. J Oral Maxillofac Pathol 18(2):155–161CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H et al (2005) Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 34(8):498–507CrossRefPubMed Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H et al (2005) Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 34(8):498–507CrossRefPubMed
9.
Zurück zum Zitat Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV et al (2013) Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck 35(10):1404–1409CrossRefPubMed Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV et al (2013) Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck 35(10):1404–1409CrossRefPubMed
10.
Zurück zum Zitat Sarode SC, Sarode GS (2013) Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses 81(4):540–543CrossRefPubMed Sarode SC, Sarode GS (2013) Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses 81(4):540–543CrossRefPubMed
11.
Zurück zum Zitat Gadbail AR, Korde S, Chaudhary MS, Sarode SC, Gondivkar SM, Dande R et al (2020) Ki67, CD105, and α-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis. Asian Pac J Cancer Prev 21(7):2067–2074CrossRefPubMedPubMedCentral Gadbail AR, Korde S, Chaudhary MS, Sarode SC, Gondivkar SM, Dande R et al (2020) Ki67, CD105, and α-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis. Asian Pac J Cancer Prev 21(7):2067–2074CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kujan O, Mello FW, Warnakulasuriya S (2021) Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Dis 27(8):1936–1946CrossRefPubMed Kujan O, Mello FW, Warnakulasuriya S (2021) Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Dis 27(8):1936–1946CrossRefPubMed
13.
Zurück zum Zitat Murthy V, Mylonas P, Carey B, Yogarajah S, Farnell D, Addison O et al (2022) Malignant transformation rate of oral submucous fibrosis: a systematic review and meta-analysis. J Clin Med 11(7):1793CrossRefPubMedPubMedCentral Murthy V, Mylonas P, Carey B, Yogarajah S, Farnell D, Addison O et al (2022) Malignant transformation rate of oral submucous fibrosis: a systematic review and meta-analysis. J Clin Med 11(7):1793CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Cai X, Yao Z, Liu G, Cui L, Li H, Huang J (2019) Oral submucous fibrosis: a clinicopathological study of 674 cases in China. J Oral Pathol Med 48(4):321–325CrossRefPubMedPubMedCentral Cai X, Yao Z, Liu G, Cui L, Li H, Huang J (2019) Oral submucous fibrosis: a clinicopathological study of 674 cases in China. J Oral Pathol Med 48(4):321–325CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Angadi PV, Rekha KP (2011) Oral submucous fibrosis: a clinicopathologic review of 205 cases in indians. Oral Maxillofac Surg 15(1):15–19CrossRefPubMed Angadi PV, Rekha KP (2011) Oral submucous fibrosis: a clinicopathologic review of 205 cases in indians. Oral Maxillofac Surg 15(1):15–19CrossRefPubMed
16.
Zurück zum Zitat Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA et al (2017) Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med 46(6):448–453CrossRefPubMed Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA et al (2017) Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med 46(6):448–453CrossRefPubMed
17.
Zurück zum Zitat Pandiar D, Ramani P, Krishnan RP, Thamilselvan S, Viswasini DR (2022) Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: recapitulation of embryonic plasticity? Oral Oncol 124:105476CrossRefPubMed Pandiar D, Ramani P, Krishnan RP, Thamilselvan S, Viswasini DR (2022) Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: recapitulation of embryonic plasticity? Oral Oncol 124:105476CrossRefPubMed
18.
Zurück zum Zitat Ganganna K, Shetty P, Shroff SE (2012) Collagen in histologic stages of oral submucous fibrosis: a polarizing microscopic study. J Oral Maxillofac Pathol 16(2):162–166CrossRefPubMedPubMedCentral Ganganna K, Shetty P, Shroff SE (2012) Collagen in histologic stages of oral submucous fibrosis: a polarizing microscopic study. J Oral Maxillofac Pathol 16(2):162–166CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 11(7):646–653PubMed Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 11(7):646–653PubMed
20.
Zurück zum Zitat Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP (1995) Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74(11):1783–1788CrossRefPubMed Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP (1995) Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74(11):1783–1788CrossRefPubMed
21.
Zurück zum Zitat Smitha B, Donoghue M (2011) Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis. J Oral Maxillofac Pathol 15(2):154–160CrossRefPubMedPubMedCentral Smitha B, Donoghue M (2011) Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis. J Oral Maxillofac Pathol 15(2):154–160CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42(6):561–568CrossRefPubMed Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42(6):561–568CrossRefPubMed
23.
Zurück zum Zitat Gray ST, Wilkins RJ, Yun K (1992) Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 141(2):301–306PubMedPubMedCentral Gray ST, Wilkins RJ, Yun K (1992) Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 141(2):301–306PubMedPubMedCentral
24.
Zurück zum Zitat Mashhadiabbas F, Mahjour F, Mahjour SB, Fereidooni F, Hosseini FS (2012) The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 114(2):240–250CrossRefPubMed Mashhadiabbas F, Mahjour F, Mahjour SB, Fereidooni F, Hosseini FS (2012) The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 114(2):240–250CrossRefPubMed
25.
Zurück zum Zitat Mishev G, Deliverska E, Hlushchuk R, Velinov N, Aebersold D, Weinstein F et al (2014) Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma. Biotechnol Biotechnol Equip 28(6):1138–1149CrossRefPubMedPubMedCentral Mishev G, Deliverska E, Hlushchuk R, Velinov N, Aebersold D, Weinstein F et al (2014) Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma. Biotechnol Biotechnol Equip 28(6):1138–1149CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Bishen KA, Radhakrishnan R, Satyamoorthy K (2008) The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 37(7):402–411CrossRefPubMed Bishen KA, Radhakrishnan R, Satyamoorthy K (2008) The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 37(7):402–411CrossRefPubMed
Metadaten
Titel
Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study
verfasst von
Deepak Pandiar
E. Aswani
Reshma Poothakulath Krishnan
Publikationsdatum
16.10.2023
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2023
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-023-01591-5

Weitere Artikel der Ausgabe 4/2023

Head and Neck Pathology 4/2023 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …